Cargando…

Potential Therapeutic Strategies for Renal Fibrosis: Cordyceps and Related Products

At present, there is no effective drug for the treatment of renal fibrosis; in particular, a safe and effective treatment for renal fibrosis should be established. Cordyceps has several medical effects, including immunoregulatory, antitumor, anti-inflammatory, and antioxidant effects, and may preven...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Wei, Wang, Yunyan, Dai, Hongmei, Deng, Junhui, Wu, Zhifen, Lin, Lirong, Yang, Jurong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304961/ https://www.ncbi.nlm.nih.gov/pubmed/35873549 http://dx.doi.org/10.3389/fphar.2022.932172

Ejemplares similares

Interaction Between Intrinsic Renal Cells and Immune Cells in the Progression of Acute Kidney Injury
por: Deng, Junhui, et al.
Publicado: (2022)

Traditional Chinese Medicine in Treating Primary Podocytosis: From Fundamental Science to Clinical Research
por: Lin, Lirong, et al.
Publicado: (2022)

Cordyceps cicadae Ameliorates Renal Hypertensive Injury and Fibrosis Through the Regulation of SIRT1-Mediated Autophagy
por: Cai, Yuzi, et al.
Publicado: (2022)

Programmed Cell Death in Sepsis Associated Acute Kidney Injury
por: Wu, Zhifen, et al.
Publicado: (2022)

Targeting the Wnt/β-Catenin Signaling Pathway as a Potential Therapeutic Strategy in Renal Tubulointerstitial Fibrosis
por: Li, Shan-Shan, et al.
Publicado: (2021)

Arsenic Species in Cordyceps sinensis and Its Potential Health Risks
por: Li, Yaolei, et al.
Publicado: (2019)

Editorial: New Insights Into Renal Fibrosis and Therapeutic Effects of Natural Products
por: Xu, Ying, et al.
Publicado: (2022)

Cordyceps spp.: A Review on Its Immune-Stimulatory and Other Biological Potentials
por: Das, Gitishree, et al.
Publicado: (2021)

Editorial: New insights into renal fibrosis and therapeutic effects of natural products volume II
por: Chen, Dan-Qian, et al.
Publicado: (2022)

Bailing capsule (Cordyceps sinensis) ameliorates renal triglyceride accumulation through the PPARα pathway in diabetic rats
por: Zhang, Qian, et al.
Publicado: (2022)

Long Non-coding RNA MEG3 Promotes Renal Tubular Epithelial Cell Pyroptosis by Regulating the miR-18a-3p/GSDMD Pathway in Lipopolysaccharide-Induced Acute Kidney Injury
por: Deng, Junhui, et al.
Publicado: (2021)

Therapeutic Potential of Polyphenols in Cardiac Fibrosis
por: Zhang, Ning, et al.
Publicado: (2018)

Immunometabolism changes in fibrosis: from mechanisms to therapeutic strategies
por: Feng, Lixiang, et al.
Publicado: (2023)

Tetramethylpyrazine: An Active Ingredient of Chinese Herbal Medicine With Therapeutic Potential in Acute Kidney Injury and Renal Fibrosis
por: Li, Jun, et al.
Publicado: (2022)

Therapeutic strategies for preventing skeletal muscle fibrosis after injury
por: Garg, Koyal, et al.
Publicado: (2015)

Cellular Senescence in Kidney Fibrosis: Pathologic Significance and Therapeutic Strategies
por: Xu, Jie, et al.
Publicado: (2020)

Trends in the Immunomodulatory Effects of Cordyceps militaris: Total Extracts, Polysaccharides and Cordycepin
por: Lee, Chun-Ting, et al.
Publicado: (2020)

Bidirectional regulatory effects of Cordyceps on arrhythmia: Clinical evaluations and network pharmacology
por: Wang, Lijuan, et al.
Publicado: (2022)

Mineralocorticoid Receptor Signaling as a Therapeutic Target for Renal and Cardiac Fibrosis
por: Tesch, Greg H., et al.
Publicado: (2017)

New insight into the management of renal excretion and hyperuricemia: Potential therapeutic strategies with natural bioactive compounds
por: Yang, Bendong, et al.
Publicado: (2022)

Natural Products Against Renal Fibrosis via Modulation of SUMOylation
por: Liu, Peng, et al.
Publicado: (2022)

Is There a Potential Therapeutic Role for Caveolin-1 in Fibrosis?
por: Shihata, Waled A., et al.
Publicado: (2017)

Function and therapeutic potential of transient receptor potential ankyrin 1 in fibrosis
por: Wei, Yicheng, et al.
Publicado: (2022)

Autophagy in renal fibrosis: Protection or promotion?
por: Dai, Rong, et al.
Publicado: (2022)

Innovative Therapeutic Strategies for Cystic Fibrosis: Moving Forward to CRISPR Technique
por: Marangi, Michele, et al.
Publicado: (2018)

Molecular Mechanisms and Potential New Therapeutic Drugs for Liver Fibrosis
por: Wang, Fa-Da, et al.
Publicado: (2022)

Mechanism of Cordyceps sinensis and its Extracts in the Treatment of Diabetic Kidney Disease: A Review
por: Liu, Wu, et al.
Publicado: (2022)

Transcriptomic analysis of the anti-inflammatory effect of Cordyceps militaris extract on acute gouty arthritis
por: Jiao, Chunwei, et al.
Publicado: (2022)

Pharmacological and therapeutic potential of Cordyceps with special reference to Cordycepin
por: Tuli, Hardeep S., et al.
Publicado: (2013)

Natural flavonoids: Potential therapeutic strategies for non-alcoholic fatty liver disease
por: Tan, Panli, et al.
Publicado: (2022)

Indole-Based Small Molecules as Potential Therapeutic Agents for the Treatment of Fibrosis
por: Qin, Rui, et al.
Publicado: (2022)

Comparative metabolic profiling of wild Cordyceps species and their substituents by liquid chromatography-tandem mass spectrometry
por: Guo, Shan, et al.
Publicado: (2022)

Potential Targeting of Renal Fibrosis in Diabetic Kidney Disease Using MicroRNAs
por: Sakuma, Hiroko, et al.
Publicado: (2020)

Cordyceps militaris extracts and cordycepin ameliorate type 2 diabetes mellitus by modulating the gut microbiota and metabolites
por: Liu, Xinyuan, et al.
Publicado: (2023)

Targeting Chitinase 1 and Chitinase 3-Like 1 as Novel Therapeutic Strategy of Pulmonary Fibrosis
por: Lee, Suh-Young, et al.
Publicado: (2022)

Interplay of EMT and CSC in Cancer and the Potential Therapeutic Strategies
por: Tanabe, Shihori, et al.
Publicado: (2020)

Research Progress of Cordyceps sinensis and Its Fermented Mycelium Products on Ameliorating Renal Fibrosis by Reducing Epithelial-to-Mesenchymal Transition
por: Zhang, Yaling, et al.
Publicado: (2023)

Histone Acetylation and Modifiers in Renal Fibrosis
por: Shen, Fengchen, et al.
Publicado: (2022)

Emerging Therapeutic Strategies for Attenuating Tubular EMT and Kidney Fibrosis by Targeting Wnt/β-Catenin Signaling
por: Hu, Lichao, et al.
Publicado: (2022)

Sphingosine 1-Phosphate Receptors: Do They Have a Therapeutic Potential in Cardiac Fibrosis?
por: Vestri, Ambra, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7odubp8pk7k0d31erigib1fmjb